| Literature DB >> 24586986 |
Seung Joo Chon1, Bo Hyon Yun1, Yeon Soo Jung1, Si Hyun Cho2, Young Sik Choi1, Suk Young Kim3, Byung Seok Lee2, Seok Kyo Seo1.
Abstract
This study aimed to investigate the association between serum levels of 25-hydroxyvitamin D [25(OH)D] and metabolic syndrome along with its associated risk factors in Korean postmenopausal women. This study was performed using data from the KNHANES 2008-2010 study and included 4,364 postmenopausal Korean women. Clinical and other objective characteristics, seasonality, and presence of metabolic syndrome with its five components were evaluated and correlated with the serum levels of 25(OH)D. Although no statistically significant associations were observed between the levels of serum 25(OH)D and the prevalence of metabolic syndrome, the adjusted OR for elevated blood pressure, elevated triglycerides (TGs), and reduced high-density lipoprotein cholesterol (HDL-C) showed tendency to decrease sequentially as tertiles of serum 25(OH)D levels increased (p for trends = 0.066, 0.043, and 0.010, respectively). Women in the highest tertile of serum 25(OH)D showed a significant decrease in the prevalence of elevated blood pressure, elevated TGs, and reduced HDL-C as compared with those in the lowest tertile of serum 25(OH)D (p = 0.020, 0.014, and 0.002, respectively). Based on these results, we consider that adequate serum levels of 25(OH)D in Korean postmenopausal women may not entirely indicate a lower risk of developing metabolic syndrome. However, adequate serum levels of 25(OH)D are significantly associated with a decrease in elevated blood pressure, elevated TGs, and reduced HDL-C levels in postmenopausal women.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24586986 PMCID: PMC3931824 DOI: 10.1371/journal.pone.0089721
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Vitamin D status according to age groups in postmenopausal women.
The lowest portion of the graph represents vitamin D deficiency; the middle portion, vitamin D insufficiency; and the highest portion, vitamin D sufficiency. Vitamin D deficiency was dominant in the postmenopausal South Korean female population (62.1%). The prevalence of vitamin D deficiency was the highest in group of <50 years, 72.5% and the lowest in group of 60–64 years, 60.1%.
Figure 2Prevalence of metabolic syndrome in postmenopausal women.
The prevalence of metabolic syndrome increased from 10.8% in women younger than 50 years to 43.1% in those aged 65–69 years.
General characteristics of postmenopausal participants compared by vitamin D status (n = 4364).
| Serum 25(OH)D | |||||
| Group 1 (%) | Group 2 (%) | Group 3 (%) |
| ||
| Number | 1454 | 1456 | 1454 | ||
| Residents district | Urban | 992 (68.2) | 811 (55.7) | 742 (51.0) | <0.001 |
| Rural | 462 (31.8) | 645 (44.3) | 712 (49.0) | ||
| Smoking | Never | 1307 (90.0) | 1314 (90.4) | 1338 (92.0) | 0.351 |
| Ever | 24 (1.7) | 26 (1.8) | 19 (1.3) | ||
| Current | 122 (8.4) | 113 (7.8) | 97 (6.7) | ||
| Alcohol consumption | None | 1238 (85.2) | 1202 (82.7) | 1219 (83.8) | 0.190 |
| Yes | 215 (14.8) | 251 (17.3) | 235 (16.2) | ||
| Physical activity | Low | 1169 (80.6) | 1125 (77.6) | 1064 (73.3) | <0.001 |
| Moderate | 128 (8.8) | 151 (10.4) | 180 (12.4) | ||
| High | 154 (10.6) | 173 (11.9) | 208 (14.3) | ||
| Education level | Elementary | 937 (64.6) | 943 (65.1) | 984 (67.9) | 0.067 |
| Middle/High | 415 (28.6) | 416 (28.7) | 400 (27.6) | ||
| College/University | 98 (6.8) | 90 (6.2) | 65 (4.5) | ||
| Occupation | Office workers | 88 (6.1) | 72 (5.0) | 42 (2.9) | <0.001 |
| Salesmen | 134 (9.3) | 152 (10.5) | 107 (7.4) | ||
| Farmers/Fishermen | 278 (19.2) | 389 (26.8) | 513 (35.4) | ||
| Housewives | 947 (65.4) | 836 (57.7) | 786 (54.3) | ||
| Income | Low | 325 (23.1) | 352 (24.5) | 378 (26.5) | 0.521 |
| (quartile/person) | Medium-Low | 365 (26.0) | 363 (25.3) | 358 (25.1) | |
| Medium-High | 356 (25.3) | 375 (26.1) | 349 (24.4) | ||
| High | 360 (25.6) | 347 (24.1) | 343 (24.0) | ||
| Diet | Frequent deficiency | 79 (5.4) | 68 (4.7) | 68 (4.7) | 0.857 |
| Occasional deficiency | 896 (61.6) | 896 (61.5) | 896 (61.6) | ||
| Enough | 479 (32.9) | 492 (33.8) | 490 (33.7) | ||
| Seasonality | Spring | 532 (36.6) | 356 (24.5) | 181 (12.4) | <0.001 |
| Summer | 267 (18.4) | 377 (25.9) | 513 (35.3) | ||
| Autumn | 242 (16.6) | 378 (26.0) | 544 (37.4) | ||
| Winter | 413 (28.4) | 345(23.7) | 216 (14.9) | ||
Metabolic syndrome and its risk factors of postmenopausal participants compared by vitamin D status (n = 4364).
| Serum 25(OH)D | ||||
| Group 1 | Group 2 | Group 3 |
| |
| WC (cm) | 82.6±9.6 | 82.4±9.0 | 82.1±9.3 | 0.375 |
| Abdominal obesity | 564 (38.8) | 553 (38.0) | 552 (38.0) | 0.872 |
| SBP (mmHg) | 127.5±18.8 | 127.2±18.2 | 125.9±18.0 | 0.044 |
| DBP (mmHg) | 77.4±10.1 | 77.9±10.2 | 76.9±9.9 | 0.020 |
| Elevated BP or medication | 905 (62.2) | 871 (59.8) | 850 (58.5) | 0.108 |
| FPG (mg/dL) | 101.5±25.7 | 100.9±24.9 | 100.5±22.6 | 0.520 |
| Elevated FPG or medication | 547(37.6) | 501 (34.4) | 515 (35.4) | 0.182 |
| TGs (mg/dL) | 143.2±88.4 | 137.1±88.2 | 131.6±80.2 | 0.001 |
| Elevated TGs or medication | 596 (41.0) | 542 (37.2) | 532 (36.6) | 0.031 |
| HDL-C (mg/dL) | 51.3±12.4 | 52.4±12.3 | 52.7±12.7 | 0.005 |
| Reduced HDL-C or medication | 801 (55.1) | 725 (49.8) | 722 (49.7) | 0.004 |
| Metabolic syndrome | 498 (34.3) | 453 (31.1) | 460 (31.6) | 0.153 |
Data are presented as mean ± standard deviation; numbers (%).
Abbreviations: WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; FPG, fasting plasma glucose; TGs, triglycerides; HDL-C, high-density lipoprotein cholesterol.
Odds ratio of metabolic syndrome and its components by serum 25(OH)D levels in postmenopausal women (n = 4364).
| Serum 25(OH)D | |||||
| Group 1 | Group 2 | Group 3 |
|
| |
| 1445 | 1445 | 1446 | |||
| Metabolic syndrome | 1.0 | 0.91 (0.77–1.06) | 0.90 (0.76–1.05) | 0.333 | 0.165 |
| Abdominal obesity | 1.0 | 0.98 (0.84–1.14) | 0.95 (0.82–1.11) | 0.825 | 0.538 |
| Elevated BP | 1.0 | 0.95 (0.81–1.12) | 0.83 (0.71–0.98) | 0.066 | 0.020 |
| Elevated fasting glucose | 1.0 | 0.89 (0.76–1.04) | 0.90 (0.77–1.06) | 0.288 | 0.259 |
| Elevated TGs | 1.0 | 0.87 (0.75–1.01) | 0.83 (0.71–0.97) | 0.043 | 0.014 |
| Reduced HDL-C | 1.0 | 0.84 (0.72–0.97) | 0.80 (0.69–0.93) | 0.010 | 0.002 |
Data are presented as OR (95% CI).
Values from comparisons of metabolic syndrome and its components among tertiles of 25(OH)D.
Values from comparisons of metabolic syndrome and its components in between the lowest and highest tertiles of 25(OH)D.
Abbreviations: OR, odds ratio; CI, confidence interval; TGs, triglycerides; HDL-C, high-density lipoprotein cholesterol.
Adjusted for age, seasonality, occupation, education, alcohol, smoking, physical activity, and HT.